Details of the Drug
General Information of Drug (ID: DMZR94D)
Drug Name |
1-(4-ethoxyphenyl)propan-2-amine
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
4-Ethoxyamphetamine; dl-p-Ethoxyamphetamine; 129476-58-0; 1-(4-ethoxyphenyl)propan-2-amine; CHEMBL161985; 135014-85-6; 1-(4-ethoxyphenyl)prop-2-ylamine; Para-Ethoxyamphetamine; Benzeneethanamine, 4-ethoxy-alpha-methyl-; AC1L2OHT; ACMC-1BZ3A; Benzeneethanamine, 4-ethoxy-alpha-methyl-, (+-)-; SCHEMBL2553013; CTK0H5621; CCAMEVFYMFXHEN-UHFFFAOYSA-N; BDBM50005270; AKOS016298265; AKOS017269155; AKOS000155579; 1-(4-Ethoxyphenyl)-2-propanamine #; 2-(4-Ethoxy-phenyl)-1-methyl-ethylamine
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 179.26 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 2.1 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 4 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||